Seigo Yoshida1, Katsumi Nakamura1, Akiyoshi Yamamoto1, Hidetoshi Akashi2, and Tetsuo Imamura3
1Radiology, Tobata Kyoritsu Hospital, Fukuoka, Japan, 2Vascular Surgery, Tobata Kyoritsu Hospital, Fukuoka, Japan, 3Surgery, Tobata Kyoritsu Hospital, Fukuoka, Japan
Synopsis
Keywords: Atherosclerosis, Cardiovascular
Feasibility of a combined
evaluation of coronary artery calcification by plain CT and severity
of PAD assessed by nonenhanced MRA was evaluated for predicting the risk of
future cerebrovascular and cardiovascular events. The result showed patients
who had coronary calcium score of 1000 or higher and more advanced PAD were
associated with 67% more subsequent cerebrovascular and cardiovascular events.
The possibility of assessing these events in a noninvasive manner has been
demonstrated, and early intervention may lead to improved patient outcomes.
INTRODUCTION
Coronary
artery disease (CAD), cerebrovascular disease (CVD), and peripheral artery disease (PAD) are
frequently combined with each other, and there is a disease concept called
polyvascular disease1). Polyvascular disease has a high risk
of developing cerebral and cardiovascular events, and proactive interventions
for CAD and PAD complications have been reported to reduce events within one
year.2) Noncontrast-enhanced
MR angiogrpahy(NC-MRA)showed excellent diagnostic ability for PAD without radiation exposure and adverse effect of contrast media.3)
The purpose of this study was to compare a combined
evaluation of coronary artery
calcification by plain CT and
severity of PAD evaluated
by using NC-MRA with subsequent cerebrovascular and cardiovascular diseases, and to investigate the feasibility of
predicting the risk of significant arterial events by non-invasive methods.MATERIALS AND METHODS
The
study type is a retrospective study with follow-up period of 2007-2022. The
subjects were 50 patients (30 males, 20 females, age 50~89;mean age
73.02 years) who underwent both peripheral NC-MRA and chest CT or coronary CT and their
subsequent course could be verified in the hospital medical records.
Peripheral
NC-MRA underwent with use of flow-spoiled FBI (fresh blood imaging) using 1.5T
or 3.0T clinical imager. Peripheral arteries were divided into 21 segments (distal
aorta, right and left common-, external-, internal- iliac artery, common-, superficial-,
deep femoral artery, popliteal artery, anterior-, posterior tibial artery,
fibular artery), and the presence of stenosis was evaluated in each
segment. Severity of peripheral arterial stenosis of each segment was scored as
follows; stenosis more than 50% receiving score 1 and occlusion receiving score
2, then all scores of a patient were summed to obtain peripheral artery disease index (PADI, PAD Index).
Coronary
calcium score (CCS) was measured with the Agatston method using non-gated chest
CT with 1-3 mm slice thickness or gated coronary artery CT with 3 mm thickness.
To evaluate correlation between CCS and
PADI, the patients were divided into 3 groups according to
CCS; group 1 had CCS from 0 to 99, group 2 from 100 to 999, group 3 more than 1000.
The patients were also divided into two groups according to PADI; group 1 had PADI less than
5, group 2 had more than 5.
Cerebrovascular
and cardiovascular events, including stroke, angina, myocardial infarction, and
acute heart failure, which occurred after peripheral NC-MRA examination were investigated
with electric medical records with follow-up periods from 1 month to
13 years 7 months, 4 years on average. The number of events at PADI from 2 to 4, from 5 to 7, and from 8 to 10 were examined
and compared for CCS group 1+2 and CCS group3. RESULTS
The
number of patients was 20 in CCS
group 1, 14 in group 2, and 16 in group 3. The number of patients was 27 in PADI group 1 and 23 in group 2. There
was no significant difference in the PADI between CCS group 1 and group 2
(p=0.93, Fig.1). The PADI in patients of CCS group 3 was significantly
higher than that of CCS group 2 (p<0.05, Fig.1). Conversely, CCS in patients
with PADI group 2 was
significantly higher than that in group 1 (p<0.05, Fig.2).
Total of 20
cerebrovascular and cardiovascular events were developed during follow-up
periods. In CCS group 1+2, the number of the events were two in PADI from 2
to 4, four in PADI from 5 to 7, and two in from 8 to 10. In CCS group 3, the number of the events were
two in PADI from 2 to 4, seven in from 5 to 7, and three in from 8 to 10,
(Fig.3). The
number of events tends to increase when the PADI is 5 or more, especially the
number in CCS group 3 was 67% greater than that in CCS group 1+2. DISCUSSTION
PADI of 5 or more was associated with an increase in the occurrence of
subsequent cerebrovascular and cardiovascular events, with the increase being
particularly pronounced in cases with CCS of 1000 or higher. Therefore, in cases
with severe coronary artery calcification with Agatston score of 1000 or more,
the addition of PAD evaluation may help assess the risk of future CVD and CAD
events.
Contrast-enhanced
CTA is currently widely used for the evaluation of PAD, but it is not
appropriate for screening due to radiation exposure
and adverse effect of contrast media. Although ankle-brachial index (ABI) is highly useful in screening for PAD, hypotension in the affected limb may
be mild if the collateral blood vessels are well developed.
In this study, PAD was evaluated using FBI, one of the
non-contrast MRA techniques. The FBI provides a clear, comprehensive image of
the lower extremity without the use of contrast media, making it useful for
determining the severity of PAD by indexing the number and degree of stenosis.CONCLUSION
Patients who had coronary calcium score of 1000 or
higher and more advanced PAD were associated with 67% more subsequent
cerebrovascular and cardiovascular events. The
possibility of assessing these events in a noninvasive manner has been
demonstrated, and early intervention may lead to improved patient outcomes.Acknowledgements
I would like to thanks Takurou Tahara and Junpei Tanaka.References
1)
Bhatt DL, Eagle KA, Ohman EM, et al.;Comparative
Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk
of or With Atherothrombosis. JAMA.2010;304(12:1350-1357)
2) Cacoub
PP. Abola MT, Baumgartner I, et al.; Cardiovascular risk factor and outcomes in
peripheral artery disease patients in the Reduction of Atherothrombosis for
Continued Health(REACH)Registry. Atherosclerosis 2009;204(2:E86-E92)
3) Miyazaki M, Sugiura S, Tateishi F, et al.:Non-contrast-enhanced
MR angiography using 3D ECG-synchronizized half-Fourier fast spin echo. J Magn
Imaging 2000: 12: 776-783